Angioedema Treatment Market Size, Share, Growth, and Industry Analysis, By Type (Allergic angioedema, Drug-induced angioedema, Idiopathic angioedema and Hereditary angioedema (HAE)), By Application (Hospitals, Online Pharmacies and Retail Pharmacies), Regional Insights, and Forecast To 2032

ANGIOEDEMA TREATMENT MARKET REPORT OVERVIEW

• 

•  Request a Free Sample to learn more about this report

The global angioedema treatment market size was USD 2249.87 million in 2021 and the market is projected to touch USD 16744.76 million by 2032 at a CAGR of 20.02% during the forecast period.

The market refers to the pharmaceutical and medical products and services that are developed and provided to treat angioedema, a medical condition characterized by sudden, severe swelling in the deeper layers of the skin, often around the eyes and lips, as well as in the throat, hands, feet, and genitals. Angioedema can be a result of various factors, including allergic reactions, medications, or underlying medical conditions. Treatment for angioedema typically depends on the underlying cause and severity of the condition.

Antihistamines are typically the first line of treatment for allergic angioedema. They work by blocking the effects of histamine, a chemical released during allergic reactions. Common antihistamines include cetirizine, loratadine, and diphenhydramine. In severe cases where there is difficulty breathing or a risk of anaphylaxis, epinephrine may be administered as an emergency measure. Epinephrine helps relieve airway constriction and reduce swelling. HAE is a genetic condition characterized by recurrent attacks of angioedema.  Medications like Berinert, Cinryze, and Haegarda are C1 esterase inhibitors that can be used to prevent and treat HAE attacks.

COVID-19 IMPACT: Supply Chain Disruptions to Hamper Demand Significantly

The COVID-19 pandemic has been unprecedented and staggering, with angioedema treatment experiencing lower-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market’s growth and demand returning to pre-pandemic levels.

COVID-19 had a life changing impact globally. The angioedema treatment market was significantly affected. The virus had various impacts on different markets. Lockdowns were imposed in several nations. This erratic pandemic caused disruptions on all sorts of businesses. Restrictions tightened during the pandemic due to increasing number of cases. Numerous Industries were affected. However, the market for angioedema treatment share experienced a reduced demand.

Pharmaceutical supply chains were affected by COVID-19-related disruptions, including lockdowns, transportation challenges, and increased demand for certain medications. This may have impacted the availability of angioedema-specific drugs and treatments. The pandemic led to disruptions in routine healthcare services, including elective medical appointments. Patients with angioedema may have experienced delays in diagnosis and treatment due to the prioritization of COVID-19 cases and concerns about potential exposure to the virus in healthcare settings.

The pandemic may have influenced patient behavior, including their awareness of the importance of adhering to treatment plans. Patients with angioedema may have had concerns about visiting healthcare facilities during the pandemic. Economic downturns resulting from the pandemic could have influenced patients' access to healthcare services and their ability to afford medications, potentially affecting the market. The market is anticipated to boost the angioedema treatment market following the pandemic.

LATEST TRENDS

"Pharmaceutical Innovation to Broaden Market Growth"

Innovations in drug development, such as novel mechanisms of action or more convenient administration methods, can significantly impact the market. New findings and therapies often emerge from clinical trials and research studies. Advances in precision medicine and targeted therapies may lead to more effective and personalized treatment options for patients with angioedema, particularly those with hereditary forms of the condition.

The continued expansion of telehealth and remote monitoring services in healthcare can influence how angioedema patients receive care and manage their condition. Monitoring trends in healthcare access and affordability, especially in the context of healthcare policy changes or economic shifts, can provide insights into how patients can access angioedema treatments. These latest developments are anticipated to boost the market.

ANGIOEDEMA TREATMENT MARKET SEGMENTATION

• 

•  Request a Free Sample to learn more about this report

• By Type

Based on type, the market is divided into Allergic angioedema, Drug-induced angioedema, Idiopathic angioedema and hereditary angioedema (HAE)).

• By Application

Based on application, the market is bifurcated into Hospitals, Online Pharmacies and Retail Pharmacies.

DRIVING FACTORS

"Increasing Prevalence of Angioedema to Boost Market Share"

The rising incidence and prevalence of angioedema, including both hereditary and acquired forms, drive the demand for effective treatments. Allergic angioedema is a common form of angioedema, and as the prevalence of allergies and allergic disorders continues to rise, the demand for effective treatment options for angioedema increases. Patient advocacy groups and organizations dedicated to angioedema awareness have played a significant role in educating the public and healthcare professionals about the condition. Increased awareness can lead to earlier diagnosis and treatment. As awareness of the condition grows, more patients seek diagnosis and treatment.

"Advancements in Medical Research to Boost Market Size"

Ongoing research in the field of angioedema has led to a better understanding of its underlying mechanisms. This research has resulted in the development of targeted therapies and more effective treatment options. Pharmaceutical companies are investing in research and development to create new medications and therapies for angioedema treatment. These innovations may include novel drugs with improved efficacy and safety profiles. These factors are anticipated to drive the angioedema treatment market share.

RESTRAINING FACTOR

"Limited Treatment Options for Some Forms to Hamper Market Share"

Patients with angioedema may develop resistance or tolerance to certain treatments over time. This can necessitate the exploration of alternative therapies. Some angioedema treatments, particularly corticosteroids, can have side effects with prolonged use. Patients may be reluctant to use these treatments due to concerns about side effects. While there have been significant advancements in the treatment of angioedema, particularly hereditary angioedema (HAE), some forms of angioedema still lack specific, effective treatments. The factors are anticipated to hinder the growth of the angioedema treatment market growth.

ANGIOEDEMA TREATMENT MARKET REGIONAL INSIGHTS

• 

•  Request a Free Sample to learn more about this report

"North America to Dominate the Market owing to Well Established Healthcare Services"

North America, including the U.S. and Canada, has historically been a significant market for pharmaceuticals and healthcare services. The prevalence of angioedema, especially hereditary angioedema (HAE), is relatively high in North America. Additionally, the presence of well-established pharmaceutical companies, advanced healthcare infrastructure, and insurance coverage can contribute to a substantial market share in this region.

KEY INDUSTRY PLAYERS

"Key Players Focus on Partnerships to Gain a Competitive Advantage "

Prominent market players are making collaborative efforts by partnering with other companies to stay ahead in the competition. Many companies are also investing in new product launches to expand their product portfolio. Mergers and acquisitions are also among the key strategies used by players to expand their product portfolio.

LIST OF TOP ANGIOEDEMA TREATMENT COMPANIES

• Sanofi SA [France]
• AstraZeneca [U.K.]
• GlaxoSmithKline [U.K.]
• Bausch Health [Canada]
• Merck & Co [U.S.]
• F. Hoffmann-La Roche AG [Switzerland]

REPORT COVERAGE

This research profiles a report with extensive studies that take into description of the firms that exist in the market affecting the forecasting period. With detailed studies done, it also offers a comprehensive analysis by inspecting the factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc. This analysis is subject to alteration if the key players and probable analysis of market dynamics changes.